PipelinePharma Logo

Generics 14

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Neostigmine methylsulfate manufacturers

14 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

14 products found

neostigmine methylsulfate

Vials, injection 0.5 mg/ml, 1 mg/ml - 10 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 56 days

neostigmine methylsulfate

Solution for injection 0,5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, INVIMA
Manufacturer #10726
This specialty biopharmaceutical company focuses on oncology and critical care medications, offering a diverse portfolio of over 650 product registrations across regions including the EU, North America, and Asia. Their expertise includes developing innovative, cost-effective drug delivery systems like microspheres, liposomes, and nanoparticles. They are recognized for manufacturing high-quality products adhering to global standards such as WHO-GMP and Schedule M certifications. Key therapy areas include oncology (with a focus on oral medications) and critical care, encompassing cardiovascular and anesthesia segments. The company has launched several first-in-market products and continues to expand its presence globally.

neostigmine methylsulfate

Vials, injection 0.5 mg/ml, 1 mg/ml - 10 ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: Approved; US RLD / Holder: "Bloxiverz / Eclat"; Indication: Cholinesterase inhibitor, indicated for the reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery;
Manufacturer #8216
This fast-growing pharmaceutical company boasts a dominant presence in Latin America, Francophone Africa, and a growing footprint in regulated markets like the EU and North America. Founded in 1990, it initially focused on ointments and creams before expanding its product range significantly. With over 4,000 global product licenses, they cater primarily to the "Bottom of the Pyramid" through their owned distribution networks. The company's manufacturing facility holds multiple certifications including US FDA approval (with three successful inspections since 2016), EU-GMP, ANVISA-Brazil, INVIMA-Colombia, and COFEPRIS-Mexico. They prioritize innovation with a significant portion of their earnings invested in research and development of safe and effective products across various dosage forms. Key therapy areas are not specified.

Want to see all 14 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.